Danthron

Danthron

SCHEMBL83688

O=C1c2cccc(O)c2C(=O)c2c(O)cccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

RXRA

The experimentally established mechanism targets of Danthron. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 1.00
ALDH1A1 P00352 4/20 1.00
TDP1 Q9NUW8 4/20 1.00
MAOA P21397 3/20 1.00
TSHR P16473 3/20 1.00
MAPK1 P28482 3/20 1.00
HPGD P15428 3/20 1.00
ALOX15 P16050 3/20 1.00
SMN1; SMN2 Q16637 3/20 1.00
HSD17B10 Q99714 3/20 1.00
LMNA P02545 2/20 1.00
MAOB P27338 2/20 1.00
HTT P42858 1/20 1.00
KMT2A Q03164 6/20 0.69
MEN1 O00255 5/20 0.69
KDM4E B2RXH2 5/20 0.69
RECQL P46063 5/20 0.69
ELANE P08246 5/20 0.69
CTSG P08311 4/20 0.69
CYP3A4 P08684 3/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Danthron SCHEMBL29356886 1.00 MAPT (1.00) MAPTALDH1A1TDP1MAOATSHR
Danthron SCHEMBL30544826 1.00 MAPT (1.00) MAPTALDH1A1TDP1MAOATSHR
Danthron SCHEMBL20565674 0.98 MAPT (0.95) MAPTALDH1A1TDP1MAOATSHR
Danthron SCHEMBL30721499 0.98 MAPT (0.95) MAPTALDH1A1TDP1MAOATSHR
Anthrarufin SCHEMBL29874705 0.92 MAOA (1.00) MAPTALDH1A1TDP1MAOATSHR
Anthrarufin SCHEMBL29363946 0.92 MAOA (1.00) MAPTALDH1A1TDP1MAOATSHR
SCHEMBL875843 0.92 MAPT (0.86) MAPTALDH1A1TDP1MAOATSHR
Anthrarufin SCHEMBL187843 0.92 MAOA (1.00) MAPTALDH1A1TDP1MAOATSHR
Anthrarufin SCHEMBL25355428 0.91 MAOA (0.86) MAPTALDH1A1TDP1MAOATSHR
1-Hydroxyanthraquinone SCHEMBL145303 0.91 MAOA (0.86) MAPTALDH1A1TDP1MAOATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4354 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250387524-A1 METHOD AND SYSTEM FOR THE PRODUCTION OF DISINFECTION AND/OR STERILISATION SOLUTIONS ESTEVEZ COMPANY CARLOS (ES) 2025-12-25 US claimed
EP-4635489-A1 COMPOSITION FOR PREVENTING OR TREATING SIDE EFFECTS OF CHOLINESTERASE INHIBITORS Dr.Noah Biotech Inc. (KR) 2025-10-22 EP claimed
US-20250262169-A1 METHODS OF TREATING COENZYME Q10 DEFICIENCY THLIVERIS, ANDREW T. 2025-08-21 US claimed
EP-4599048-A1 COMPOSITIONS AND METHODS FOR SMALL MOLECULE BASED EXPANSION OF PLURIPOTENT STEM CELLS Trailhead Biosystems Inc. (US) 2025-08-13 EP claimed
EP-4569090-A2 METHODS AND COMPOSITIONS FOR GENERATING OLIGODENDROCYTE PROGENITOR CELLS Trailhead Biosystems Inc. (US) 2025-06-18 EP claimed
EP-4549429-A1 METHOD AND SYSTEM FOR THE PRODUCTION OF DISINFECTION AND/OR STERILISATION SOLUTIONS Universitat Jaume I (ES) 2025-05-07 EP claimed
CN-119764506-A Negative electrode electrolyte of zinc-iron flow battery and zinc-iron flow battery 中国石油大学(北京) 2025-04-04 CN claimed
WO-2025071488-A1 CAPACITY BOOSTERS FOR VANADIUM-BASED ELECTROLYTES NATIONAL UNIVERSITY OF SINGAPORE (SG) 2025-04-03 WO claimed
CN-119654404-A Methods and compositions for producing oligodendrocyte progenitor cells 特雷尔赫德生物系统股份有限公司 2025-03-18 CN claimed
CN-119425636-A Molecularly imprinted composite core-shell adsorption material, preparation method and application 南开大学 2025-02-14 CN claimed
EP-0091225-A2 Anthraquinone compounds IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1983-10-12 EP claimed
EP-0063490-A1 Lactation improvement method ELI LILLY AND COMPANY (US) 1982-10-27 EP claimed
US-4342701-A Process for the preparation of 4,5-dinitro-1,8-dihydroxyanthraquinone BAYER AKTIENGESELLSCHAFT (DE) 1982-08-03 US claimed
EP-0046270-A1 Novel derivatives of bio-affecting phenolic compounds and pharmaceutical composition containing them INTERx RESEARCH CORPORATION (US) 1982-02-24 EP claimed
EP-0000341-B1 PROCESS FOR PREPARING PRACTICALLY PURE 1-AMINO-8-NITRO-4,5-DIHYDROXY ANTHRAQUINONE BASF Aktiengesellschaft (DE) 1981-02-25 EP claimed
EP-0015486-A2 Process for the preparation of 4,5-dinitro-1,8-dihydroxyanthraquinone BAYER AG (DE) 1980-09-17 EP claimed
US-4154747-A Production of virtually pure 1-amino-8-nitro-4,5-dihydroxyanthraquinone BASF AKTIENGESELLSCHAFT (DE) 1979-05-15 US claimed
EP-0000341-A1 Process for preparing practically pure 1-amino-8-nitro-4,5-dihydroxy anthraquinone BASF Aktiengesellschaft (DE) 1979-01-24 EP claimed
US-4041164-A ALUMINUM CHELATES OF A HYDROXY-QUINONE HOECHST AKTIENGESELLSCHAFT (DT) 1977-08-09 US claimed
US-4002654-A Process for the preparation of dihydroxyanthraquinones BAYER AKTIENGESELLSCHAFT (DT) 1977-01-11 US claimed